XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.1
RESTRUCTURING - Narrative (Details)
$ in Thousands
1 Months Ended 3 Months Ended
Apr. 30, 2022
USD ($)
position
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
2020 Restructuring Initiative      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges   $ 7,395  
2020 Restructuring Initiative | Accelerated depreciation      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     $ 51,000
2020 Restructuring Initiative | Asset impairments      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     49,500
2020 Restructuring Initiative | Inventory adjustments      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     11,600
2020 Restructuring Initiative | Employee Separation, Continuity and Other Benefit-Related Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     53,900
2020 Restructuring Initiative | Other restructuring charges      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     3,500
2020 Restructuring Initiative | Operating segments | Generic Pharmaceuticals      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges   5,000  
Restructuring and related cost, cost incurred to date     134,300
April, 2022 Restructuring Initiative      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges   29,432  
Restructuring and related cost, expected number of positions eliminated | position 190    
April, 2022 Restructuring Initiative | Inventory adjustments      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     34,900
April, 2022 Restructuring Initiative | Employee Separation, Continuity and Other Benefit-Related Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     28,300
April, 2022 Restructuring Initiative | Other restructuring charges      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     8,700
April, 2022 Restructuring Initiative | Inidentifiable Intangible assets      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     180,200
April, 2022 Restructuring Initiative | Operating segments | Generic Pharmaceuticals      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges   $ 16,300  
April, 2022 Restructuring Initiative | Operating segments | Branded Pharmaceuticals      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, cost incurred to date     $ 238,600
April, 2022 Restructuring Initiative | Minimum      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related costs, expected cost savings $ 105,000    
April, 2022 Restructuring Initiative | Maximum      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related costs, expected cost savings $ 125,000